“ASSESSMENT OF SERUM SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) AS A POTENTIAL RISK MARKER IN OBESE WOMEN WITH PREDICTIVE MARKER FOR POLYCYSTIC OVARY SYNDROME”, CMN, vol. 6, no. 2, pp. 4972–4983, Sep. 2024, Accessed: Aug. 22, 2025. [Online]. Available: http://cahiersmagellanes.com/index.php/CMN/article/view/782